Virus-activated killer immune cells therapy(Binhui Biotechnology)

N/A

Report date: 2023/11/22 17:58:27

Base Information

Drug NameVirus-activated killer immune cells therapy(Binhui Biotechnology)
Drug Alias NameVAK(Binhui Biotechnology)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPleural Effusion, Malignant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesWuhan Binhui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Binhui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPleural Effusion, Malignant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A